Dr. Peter A. Lanasa Sr., MD

  • Arlington, TX
  • Radiation oncologist
NPI1265482475PAC ID1355326869
Medicare services, 2024
5,513
Medicare patients, 2024
181
Part D claims, 2024
220
Publications
4
Hospital affiliations
2
Practice address
5001 S Cooper St, Arlington, TX 76017
Practice phone
Call (866) 367-8768
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Urology Partners of North Texas

Arlington, Texas

See all 5 affiliations

Find Dr. Lanasa's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Peter A. Lanasa Sr. is a radiation oncologist in Arlington, Texas

Dr. Lanasa practices at Urology Partners of North Texas in Arlington, Texas.

Dr. Lanasa's NPI, 1265482475, was assigned on May 10, 2006. Dr. Lanasa graduated from UVA School of Medicine in 1989. Dr. Lanasa holds Texas license L8788.

NPI and contact details
Medicare PAC ID
1355326869
NPI enumeration date
May 10, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(866) 367-8768
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
63
Medical school graduation
1989

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Peter A. Lanasa Sr. practices at Urology Partners of North Texas in Arlington, Texas

Dr. Lanasa's primary practice is Urology Partners of North Texas, at 5001 S Cooper St, Arlington, TX 76017 in Tarrant County. The practice phone is (866) 367-8768.

  • Urology Partners of North Texas
    5001 S Cooper St, Arlington, TX 76017 · Tarrant CountyPhone(866) 367-8768

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Peter A. Lanasa Sr. is affiliated with 3 sites of care and 2 medical groups

Dr. Lanasa's primary practice is Urology Partners of North Texas in Arlington, Texas. Dr. Lanasa is also affiliated with USMD Hospital at Arlington. The medical group on file is Urology Partners of North Texas. Dmand AI also links Dr. Lanasa to 1 more hospital and 1 medical group, each named with a free account.

See all 5 affiliations for Dr. Lanasa

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Peter A. Lanasa Sr.'s practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lanasa practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Urology Partners of North TexasAvailable with a free account
+2 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Lanasa practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Peter A. Lanasa Sr. is one of 401 radiation oncologists in Texas

Radiation oncology is Dr. Lanasa's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Lanasa is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Lanasa's licenses on file in 4 states: Texas, New York, Pennsylvania and New Jersey.

Specialties and state licenses

  • Radiation oncology, TexasPrimaryLicense L8788 · 2004 to 2026 · taxonomy 2085R0001X
  • New York license1992 to 2006
  • Pennsylvania license1996 to 2004
  • New Jersey license1990 to 1993

Clinical focus

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain cancer radiation, breast cancer radiation, head & neck cancer radiation, lung cancer radiation and prostate cancer radiation among the conditions Dr. Lanasa treats.

Radiation oncologists near Dr. Lanasa

Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.

401radiation oncologists in Texas
3radiation oncologists in Arlington

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Peter A. Lanasa Sr. billed Medicare for 5,513 services in 2024

CMS data shows 5,513 Medicare services from Dr. Lanasa across 16 procedure codes in 2024, for 181 Medicare patients. Medicare paid $819,885 for them. Every service was in an office.

Medicare services, 20245,513
Medicare patients181
Paid by Medicare$819,885
Procedure codes16

Dr. Lanasa's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Imaging
2023: 3,6372024: 3,619No change
Other services
2023: 02024: 1,450
Drugs given in the office
2023: 2182024: 18316%
Office and hospital visits
2023: 1792024: 15613%
Tests and treatments
2023: 632024: 5316%
Lab and pathology
2023: 832024: 3360%
Surgery
2023: 02024: 19

Dr. Lanasa compared with the Texas median for radiation oncologists, 2024

  • Dr. Lanasa
  • Texas median
Medicare services
5,513vs 1,4723.7 times
Medicare patients
181vs 16410% above
Part D claims
162vs 414.0 times

Medians across 370 radiation oncologists in Texas with Dmand AI profiles that report each measure.

Dr. Lanasa's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Lanasa

Need commercial claims for Dr. Lanasa?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Lanasa and other radiation oncologists in Texas.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Peter A. Lanasa Sr. treated 181 Medicare patients in 2024, average age 74

CMS counts 181 Medicare patients who saw Dr. Lanasa in 2024. The largest group is 65 to 74, with 93 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lanasa's median patient age at 72, with 1% women.

Medicare patients, 2024181
Average age74
Average risk score1.09

Dr. Lanasa's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Chronic conditions among Dr. Lanasa's Medicare patients, 2024

  1. Cancer75%
  2. High blood pressure75%
  3. High cholesterol75%
  4. Diabetes33%
  5. Arthritis31%
  6. Ischemic heart disease31%
  7. Chronic kidney disease22%
  8. Atrial fibrillation19%

Share of Medicare patients with each condition. A patient can have several.

Dr. Lanasa's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 72

Patient panel by sex, all payers

  • Women1%
  • Men98%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Peter A. Lanasa Sr. wrote 220 Medicare Part D claims in 2024

In 2024, Dr. Lanasa wrote 220 Medicare Part D claims for 117 patients. 98% of them were for generic drugs. CMS names the drug for 162 of them, across 3 drugs with 11 or more claims each, at $1,871 in total drug cost. In 2023, CMS named 302 claims across 4 drugs.

Part D claims, 2024220
Drugs named by CMS3
Total drug cost$1,871
Part D patients117

Dr. Lanasa's Part D claims by kind of drug, 2024

  • Generic215 claims98%
  • Brand-name and other5 claims2%

Dr. Lanasa's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 3022024: 16246%

Drugs named by CMS: 3 in 2024, 4 in 2023.

See all prescribing by Dr. Lanasa

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

How Dr. Peter A. Lanasa Sr. takes part in Medicare

Dr. Lanasa accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find radiation oncologists like Dr. Lanasa by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Peter A. Lanasa Sr. has 4 publications on record

Dmand AI links 4 papers to Dr. Lanasa. The most frequent topics are Cell Survival, Cell Transformation, Neoplastic and Cricetinae.

Papers4

Topics Dr. Lanasa writes about most

  • Cell Survival
  • Cell Transformation, Neoplastic
  • Cricetinae
  • Mesocricetus
  • Misoprostol
  • Radiation-Protective Agents
  • Cells, Cultured
  • Embryo, Mammalian

Recent publications by Dr. Lanasa

See all 4 publications and co-authors

See who Dr. Lanasa researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lanasa works with, so you can find a warm path to the right radiation oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Peter A. Lanasa Sr. received $142 in industry payments from 2017 to 2025

CMS Open Payments shows 7 general payments to Dr. Lanasa from 5 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $48.

General payments to Dr. Lanasa by program year, 2017 to 2025

Companies that paid Dr. Lanasa the most, 2017 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Lanasa

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Peter A. Lanasa Sr. graduated from UVA School of Medicine

Dr. Lanasa graduated from UVA School of Medicine in 1989.

  1. Medical schoolUVA School of Medicine
  2. Board certified in radiation oncologyAmerican Board of Radiology

Source: Dmand AI Professional Profile Data

Dr. Peter A. Lanasa Sr. accepts plans from 21 insurance carriers

Dr. Lanasa is in network with 21 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.

Plan types Dr. Lanasa accepts, by number of carriers

  1. PPO13
  2. HMO12
  3. Medicare10
  4. POS6
  5. EPO4
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Dr. Peter A. Lanasa Sr.'s profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Peter A. Lanasa Sr.

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Peter A. Lanasa Sr.'s NPI number?

Dr. Peter A. Lanasa Sr.'s NPI number is 1265482475. It was assigned on May 10, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Peter A. Lanasa Sr.?

Dr. Peter A. Lanasa Sr. is a radiation oncologist in Arlington, Texas. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).

Where does Dr. Peter A. Lanasa Sr. practice?

Dr. Lanasa practices at 5001 S Cooper St, Arlington, TX 76017. Dr. Lanasa's primary practice is Urology Partners of North Texas in Arlington, Texas. Dmand AI also links Dr. Lanasa to 1 hospital and 1 medical group.

What is Dr. Peter A. Lanasa Sr.'s office phone number?

The practice phone on file for Dr. Lanasa is (866) 367-8768.

What is Dr. Peter A. Lanasa Sr.'s medical license number?

Dr. Lanasa holds Texas license L8788, one of the licenses on file in 4 states.

Which states has Dr. Peter A. Lanasa Sr. been licensed in?

Dmand AI has state licenses on file for Dr. Lanasa in Texas (2004 to 2026), New York (1992 to 2006), Pennsylvania (1996 to 2004) and New Jersey (1990 to 1993).

Which hospitals is Dr. Peter A. Lanasa Sr. affiliated with?

Dr. Lanasa is affiliated with USMD Hospital at Arlington. Dmand AI links Dr. Lanasa to 1 more hospital.

What medical group is Dr. Peter A. Lanasa Sr. part of?

Dr. Lanasa is linked to Urology Partners of North Texas. Dmand AI links Dr. Lanasa to 1 more medical group.

Does Dr. Peter A. Lanasa Sr. accept Medicare?

Yes. CMS data shows Dr. Lanasa billed Medicare for 5,513 services in 2024, and Dr. Lanasa accepts Medicare assignment.

How many Medicare patients does Dr. Peter A. Lanasa Sr. see?

CMS counts 181 Medicare patients who saw Dr. Lanasa in 2024, with an average age of 74.

Show 8 more questionsShow fewer questions

Is Dr. Peter A. Lanasa Sr. board certified?

Yes. Dr. Lanasa is board certified in radiation oncology by the American Board of Radiology.

What services does Dr. Peter A. Lanasa Sr. bill to Medicare?

In 2024, Dr. Lanasa's most billed Medicare services were radiation oncology (77014), medicare service (G6015) and radiation oncology (77427).

Where did Dr. Peter A. Lanasa Sr. go to medical school?

Dr. Lanasa graduated from UVA School of Medicine in 1989.

What drugs does Dr. Peter A. Lanasa Sr. prescribe most?

In 2024 Medicare Part D data, Dr. Lanasa's most prescribed drugs by claims were Tamsulosin HCl, Finasteride and Venlafaxine HCl ER.

Has Dr. Peter A. Lanasa Sr. received payments from drug or device companies?

CMS Open Payments shows $142 in general payments to Dr. Lanasa from 5 companies from 2017 to 2025. The largest total came from Pfizer Inc.

How long has Dr. Peter A. Lanasa Sr. been practicing?

Dr. Lanasa graduated from medical school in 1989, 37 years ago.

Does Dr. Peter A. Lanasa Sr. do research?

Dmand AI links 4 publications to Dr. Lanasa.

What insurance does Dr. Peter A. Lanasa Sr. accept?

Dr. Lanasa is in network with 21 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.

Selling to radiation oncology practices?

See radiation oncologists in Texas by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)